Related Experiment Video
Updated: Sep 6, 2025

Spatiotemporally Controlled Nuclear Translocation of Guests in Living Cells Using Caged Molecular Glues as Photoactivatable Tags
Published on: January 17, 2019
Molecular glues to stabilise protein-protein interactions
Lorenzo Soini1, Seppe Leysen2, Jeremy Davis3
1Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, the Netherlands; Department of Structural Biology and Biophysics, UCB Biopharma UK, Slough, UK.
Targeting protein-protein interactions (PPIs) offers therapeutic potential for diseases. Stabilizing PPIs, particularly with 14-3-3 proteins, is a promising new drug discovery strategy.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Protein-protein interactions (PPIs) are crucial in cellular signaling pathways.
- Dysregulated PPIs are implicated in the pathology of various diseases.
- Modulating PPIs presents significant therapeutic opportunities.
Purpose of the Study:
- To explore the therapeutic potential of modulating protein-protein interactions (PPIs).
- To highlight the emerging strategy of stabilizing PPIs for drug discovery.
- To introduce 14-3-3 proteins as potential targets for PPI stabilization therapies.
Main Methods:
- Review of existing literature on PPI modulation strategies.
- Analysis of the role of PPI stabilization in targeted protein degradation (TPD).
- Examination of 14-3-3 proteins as a class of interaction partners.
Main Results:
- Inhibition of PPIs was an initial therapeutic approach.
- Stabilization of PPIs is now recognized as a viable therapeutic strategy.
- Targeted protein degradation (TPD) utilizes PPI stabilization for therapeutic effect.
- 14-3-3 proteins represent a novel target class for PPI stabilization-based drug discovery.
Conclusions:
- Modulating protein-protein interactions (PPIs) is a key strategy in disease treatment.
- Stabilizing PPIs, including those involving 14-3-3 proteins, offers new therapeutic avenues.
- Targeted protein degradation (TPD) and 14-3-3 protein interactions are promising areas for future drug development.
Related Concept Videos
Protein-protein Interfaces
Noncovalent Attractions in Biomolecules
Four types of noncovalent interactions are hydrogen bonds, van der Waals forces, ionic bonds, and hydrophobic interactions.
Hydrogen bonding results from the electrostatic attraction of a hydrogen atom covalently bonded to a strong-electronegative atom like oxygen,...
Protein Folding
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

